{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:24:44Z","timestamp":1768274684919,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00423-021-02354-y","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T23:34:21Z","timestamp":1634945661000},"page":"2817-2825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of non-primary origin"],"prefix":"10.1007","volume":"406","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2634-4878","authenticated-orcid":false,"given":"Fabio","family":"Carboni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orietta","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Settimio","family":"Zazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Massimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Sperduti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"key":"2354_CR1","doi-asserted-by":"publisher","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","volume":"2","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A et al (2019) Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. Jama Netw Open 2:e186847","journal-title":"Jama Netw Open"},{"key":"2354_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjsurg.2019.09.017","volume":"219","author":"EW Beal","year":"2020","unstructured":"Beal EW, Ahmed A, Grotz T et al (2020) Trends in the indications for short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg 219:478\u2013483","journal-title":"Am J Surg"},{"key":"2354_CR3","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jso.26371","volume":"123","author":"A Nichiforkin","year":"2021","unstructured":"Nichiforkin A, Nikiforchin A, Gushchin V et al (2021) Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience. J Surg Oncol 123:1030\u20131044","journal-title":"J Surg Oncol"},{"key":"2354_CR4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jso.25642","volume":"120","author":"LS Kyang","year":"2019","unstructured":"Kyang LS, Alzahrani NA, Valle SJ et al (2019) Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: single-institutional experience with 1225 cases. J Surg Oncol 120:794\u2013802","journal-title":"J Surg Oncol"},{"key":"2354_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11605-020-04771-8","volume":"25","author":"MC Morris","year":"2021","unstructured":"Morris MC, Cloyd JM, Hays J, Patel SH (2021) The role of hyperthermic intraperitoneal chemotherapy for non-colorectal peritoneal surface malignancies. J Gastrointest Surg 25:303\u2013318","journal-title":"J Gastrointest Surg"},{"key":"2354_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00423-019-01805-x","volume":"404","author":"V Narasimhan","year":"2019","unstructured":"Narasimhan V, Das A, Warrier S et al (2019) Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases. Langenbecks Arch Surg 404:527\u2013539","journal-title":"Langenbecks Arch Surg"},{"key":"2354_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jso.24248","volume":"113","author":"G Passot","year":"2016","unstructured":"Passot G, Vaudoyer D, Villeneuve L et al (2016) What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1.125 procedures. J Surg Oncol 113:796\u2013803","journal-title":"J Surg Oncol"},{"key":"2354_CR8","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1007\/s11605-019-04368-w","volume":"24","author":"F Carboni","year":"2020","unstructured":"Carboni F, Federici O, Giofr\u00e8 M, Valle M (2020) An 18-year experience in diagnostic laparoscopy of peritoneal carcinomatosis: results from 744 patients. J Gastrointest Surg 24:2096\u20132103","journal-title":"J Gastrointest Surg"},{"key":"2354_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1055-3207(03)00048-6","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH (2003) Peritonectomy procedures. Surg Oncol Clin N Am 12:703\u2013727","journal-title":"Surg Oncol Clin N Am"},{"key":"2354_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/cancers13030523","volume":"13","author":"F Carboni","year":"2021","unstructured":"Carboni F, Federici O, Sperduti I et al (2021) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from epithelial ovarian cancer: a 20-year single-center experience. Cancers (Basel) 13:523","journal-title":"Cancers (Basel)"},{"key":"2354_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejso.2020.08.016","volume":"47","author":"F Carboni","year":"2021","unstructured":"Carboni F, Federici O, Zazza S et al (2021) Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a 20-year experience. Eur J Surg Oncol 47:143\u2013148","journal-title":"Eur J Surg Oncol"},{"key":"2354_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","volume":"19","author":"L Colantonio","year":"2015","unstructured":"Colantonio L, Clarioni C, Fabrizi L et al (2015) A randomized trial of goal directed vs. standard therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg 19:722\u2013729","journal-title":"J Gastrointest Surg"},{"key":"2354_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ejso.2013.10.015","volume":"40","author":"M Valle","year":"2014","unstructured":"Valle M, Federici O, Carboni F et al (2014) Postoperative infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carinomatosis: proposal and results from a prospective protocol study of prevention, surveillance and treatment. Eur J Surg Oncol 40:950\u2013656","journal-title":"Eur J Surg Oncol"},{"key":"2354_CR14","unstructured":"U.S. Department of Health and Humans Services, National Cancer Intitutes of Health. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published: May 28, 2009 (v4.03: June 14, 2010), nd"},{"key":"2354_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.suc.2020.02.009","volume":"100","author":"E Pletcher","year":"2020","unstructured":"Pletcher E, Gleeson E, Labow D (2020) Peritoneal cancers and hyperthermic intraperitoneal chemotherapy. Surg Clin North Am 100:589\u2013613","journal-title":"Surg Clin North Am"},{"key":"2354_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00595-020-02180-7","volume":"51","author":"T Kitai","year":"2021","unstructured":"Kitai T (2021) The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan. Surg Today 51:1085\u20131098","journal-title":"Surg Today"},{"key":"2354_CR17","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP et al (2016) Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol 17:1709\u20131719","journal-title":"Lancet Oncol"},{"key":"2354_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3390\/jcm9030748","volume":"9","author":"EW Beal","year":"2020","unstructured":"Beal EW, Suarez-Kelly LP, Kimbrough CW et al (2020) Impact of neoadjuvant chemotherapy on the outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a multi-institutional retrospective review. J Clin Med 9:748","journal-title":"J Clin Med"},{"key":"2354_CR19","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/ans.13152","volume":"86","author":"N Alzahrani","year":"2016","unstructured":"Alzahrani N, Ferguson JS, Valle SJ et al (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia. ANZ J Surg 86:937\u2013941","journal-title":"ANZ J Surg"},{"key":"2354_CR20","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00384-018-3146-z","volume":"33","author":"P Piso","year":"2018","unstructured":"Piso P, Stierstorfer K, Gerken M, Klinkhammer-Schalke M (2018) Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer. Int J Col Dis 33:1559\u20131667","journal-title":"Int J Col Dis"},{"key":"2354_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet Qu\u00e9net","year":"2021","unstructured":"Quenet Qu\u00e9net F, Elias D et al (2021) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22:256\u2013266","journal-title":"Lancet Oncol"},{"key":"2354_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ejso.2020.09.017","volume":"47","author":"RA Nagourney","year":"2021","unstructured":"Nagourney RA, Evans S, Tran PH, Nagourney AJ, Sugarbaker PH (2021) Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. Eur J Surg Oncol 47:738\u2013742","journal-title":"Eur J Surg Oncol"},{"key":"2354_CR23","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/S1470-2045(21)00088-7","volume":"22","author":"F Carboni","year":"2021","unstructured":"Carboni F, Valle M (2021) Limitations of the PRODIGE 7 trial. Lancet Oncol 22:e176","journal-title":"Lancet Oncol"},{"key":"2354_CR24","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.ejso.2020.04.018","volume":"46","author":"C Bakkers","year":"2020","unstructured":"Bakkers C, van Erning FN, Rovers KP et al (2020) Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: a nationwide comparative study. Eur J Surg Oncol 46:1902\u20131907","journal-title":"Eur J Surg Oncol"},{"key":"2354_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4251\/wjgo.v12.i8.903","volume":"12","author":"J Spiegelberg","year":"2020","unstructured":"Spiegelberg J, Neeff H, Holzner P et al (2020) Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. World J Gastrointest Oncol 12:903\u2013917","journal-title":"World J Gastrointest Oncol"},{"key":"2354_CR26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1245\/s10434-016-5712-3","volume":"24","author":"K Waite","year":"2017","unstructured":"Waite K, Youssef H (2017) The role of neoadjuvant and adjuvant systemic chemotherapy with cytoreductive surgery and heated intraperitoneal chemotherapy for colorectal peritoneal metastases: a systematic review. Ann Surg Oncol 24:705\u2013720","journal-title":"Ann Surg Oncol"},{"key":"2354_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1186\/s12885-019-5545-0","volume":"19","author":"KP Rovers","year":"2019","unstructured":"Rovers KP, Bakkers C, Simkens GAAM et al (2019) Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6). BMC Cancer 19:390","journal-title":"BMC Cancer"},{"key":"2354_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1159\/000493493","volume":"34","author":"PK Garg","year":"2018","unstructured":"Garg PK, Brandl A, Rau B (2018) Hyperthermic intraperitoneal chemotherapy - fading perspective in the light of modern systemic chemotherapy? Visc Med 34:412\u2013416","journal-title":"Visc Med"},{"key":"2354_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/jso.25967","volume":"122","author":"JC Chen","year":"2020","unstructured":"Chen JC, Beal EW, Hays J et al (2020) Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer. J Surg Oncol 122:388\u2013398","journal-title":"J Surg Oncol"},{"key":"2354_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F et al (2016) A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified delphi process. Am J Surg Pathol 40:14\u201326","journal-title":"Am J Surg Pathol"},{"key":"2354_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1245\/s10434-019-07518-1","volume":"27","author":"NL Leigh","year":"2020","unstructured":"Leigh NL, Solomon D, Feingold D et al (2020) Improved survival with experience: a 10-year learning curve in hyperthermic intraperitoneal chemotherapy and cytoreductive surgery. Ann Surg Oncol 27:222\u2013231","journal-title":"Ann Surg Oncol"},{"key":"2354_CR32","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1002\/cam4.3009","volume":"9","author":"BC Kolla","year":"2020","unstructured":"Kolla BC, Petersen A, Chengappa M et al (2020) Impact of adjuvant chemotherapy on outcomes in appendiceal cancer. Cancer Med 9:3400\u20133406","journal-title":"Cancer Med"},{"key":"2354_CR33","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.ejso.2020.11.138","volume":"47","author":"A Sarkar","year":"2021","unstructured":"Sarkar A, Lansom J, Dey A et al (2021) Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumours. Eur J Surg Oncol 47:1406\u20131410","journal-title":"Eur J Surg Oncol"},{"key":"2354_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1245\/s10434-017-6315-3","volume":"25","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos KI, Bartlett D, Moran B et al (2018) PCI is not predictive of survival after complete CRS\/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Ann Surg Oncol 25:674\u2013678","journal-title":"Ann Surg Oncol"},{"key":"2354_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10120-019-00978-0","volume":"23","author":"B Rau","year":"2020","unstructured":"Rau B, Brandl A, Piso P et al (2020) Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer 23:11\u201322","journal-title":"Gastric Cancer"},{"key":"2354_CR36","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","volume":"26","author":"I Manzanedo","year":"2019","unstructured":"Manzanedo I, Pereira F, Rihuete Caro C et al (2019) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish Group of Peritoneal Oncologic Surgery (GECOP). Ann Surg Oncol 26:2615\u20132621","journal-title":"Ann Surg Oncol"},{"key":"2354_CR37","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V et al (2019) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol 37:2028\u20132040","journal-title":"J Clin Oncol"},{"key":"2354_CR38","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","volume":"23","author":"CS Chia","year":"2016","unstructured":"Chia CS, You B, Decullier E et al (2016) Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol 23:1971\u20131979","journal-title":"Ann Surg Oncol"},{"key":"2354_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejso.2020.10.006","volume":"47","author":"A Brandl","year":"2021","unstructured":"Brandl A, Yonemura Y, Glehen O, Sugarbaker P, Rau B (2021) Retrospective analysis of patients with signet ring subtype of colorectal cancer with peritoneal metastasis treated with CRS & HIPEC. Eur J Surg Oncol 47:172\u2013180","journal-title":"Eur J Surg Oncol"},{"key":"2354_CR40","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1002\/cam4.2204","volume":"8","author":"R Yarema","year":"2019","unstructured":"Yarema R, Mielko J, Fetsych T et al (2019) Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: a retrospective cooperative Central-Eastern European study. Cancer Med 8:2877\u20132885","journal-title":"Cancer Med"},{"key":"2354_CR41","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/jso.26366","volume":"123","author":"WJ Koemans","year":"2021","unstructured":"Koemans WJ, van der Kaaij RT, Wassenaar ECE et al (2021) Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial. J Surg Oncol 123:904\u2013910","journal-title":"J Surg Oncol"},{"key":"2354_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejso.2018.10.528","volume":"45","author":"Y Wang","year":"2019","unstructured":"Wang Y, Ren F, Chen P et al (2019) Effects of cytoreductive surgery plus hyperthermic intraperitoneal chemotheraly (HIPEC) versus cytoreductive surgery for ovarian cancer patients: a systematic revieew and meta-analysis. Eur J Surg Oncol 45:301\u2013309","journal-title":"Eur J Surg Oncol"},{"key":"2354_CR43","doi-asserted-by":"publisher","first-page":"e18355","DOI":"10.1097\/MD.0000000000018355","volume":"98","author":"SI Kim","year":"2019","unstructured":"Kim SI, Cho J, Lee EJ et al (2019) Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy. A systematic review and meta-analysis. Medicine (Baltimore) 98:e18355","journal-title":"Medicine (Baltimore)"},{"key":"2354_CR44","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378:230\u2013240","journal-title":"N Engl J Med"},{"issue":"Suppl 24","key":"2354_CR45","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1002\/cncr.32505","volume":"125","author":"SN Koole","year":"2019","unstructured":"Koole SN, van Driel WJ, Sonke GS (2019) Hyperthermic intraperitoneal chemotherapy for ovarian cancer: the heat is on. Cancer 125(Suppl 24):4587\u20134593","journal-title":"Cancer"},{"key":"2354_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12957-020-01938-0","volume":"18","author":"N Leigh","year":"2020","unstructured":"Leigh N, Solomon D, Pletcher E et al (2020) The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 18:182","journal-title":"World J Surg Oncol"},{"key":"2354_CR47","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","volume":"218","author":"EA Levine","year":"2014","unstructured":"Levine EA, Stewart JH 4th, Shen P et al (2014) Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg 218:573\u2013585","journal-title":"J Am Coll Surg"},{"key":"2354_CR48","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s00464-017-5923-0","volume":"32","author":"P von Breitenbuch","year":"2018","unstructured":"von Breitenbuch P, Boerner T, Jeiter T, Piso P, Schlitt HJ (2018) Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies. Surg Endosc 32:2288\u20132294","journal-title":"Surg Endosc"},{"key":"2354_CR49","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1245\/s10434-015-4958-5","volume":"23","author":"RA Marmor","year":"2016","unstructured":"Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM (2016) Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery. Ann Surg Oncol 23:1461\u20131467","journal-title":"Ann Surg Oncol"},{"key":"2354_CR50","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/jso.23924","volume":"111","author":"P Tabrizian","year":"2015","unstructured":"Tabrizian P, Jayakrishnan TT, Zacharias A et al (2015) Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: a multi-institutional analysis. J Surg Oncol 111:1035\u20131040","journal-title":"J Surg Oncol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02354-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-021-02354-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-021-02354-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T16:05:15Z","timestamp":1699718715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-021-02354-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2354"],"URL":"https:\/\/doi.org\/10.1007\/s00423-021-02354-y","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,23]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}